• Disease areas
  • Science & technology
  • Partnering & innovation
  • Sustainable business
  • Careers
  • About us
  • Our products
  • Investors
  • News & media
  • Patient help
  • Contact us
  1. Insulin100

    A century of innovation in diabetes care

  2. COVID-19 & diabetes

    If you have questions about physical and mental concerns during COVID-19, click the link below.

Latest news

{{'2021-03-26T12:57:59Z' | dateFormatFilter}}

Saxenda® recommended for approval by European Medicines Agency committee for the treatment of obesity in adolescents aged 12–17 years

Read more

{{'2021-03-25T16:12:43Z' | dateFormatFilter}}

Correction: Resolutions from the Annual General Meeting of Novo Nordisk A/S

Read more

{{'2021-03-25T15:13:09Z' | dateFormatFilter}}

Resolutions from the Annual General Meeting of Novo Nordisk A/S

Read more

News archive

Career Opportunities

Dear colleague

Please click here to go directly to our internal career site to view all our current job opening.

Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.

 

 

 

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

View financial results Visit Capital Markets day News & IR Materials Annual General Meeting 2021

Annual Report

Front cover of the Novo Nordisk Annual Report 2020

Annual Report 2020

Novo Nordisk Annual Report

NOVO NORDISK HQ

Novo Nordisk A/S
Novo Allé 1
2880 Bagsværd
Denmark
+45-4444-8888
CVR-no. 24256790

Helpful links

Patient help Suppliers help Product list Contact us Annual Report

Follow us

LinkedIn YouTube Facebook Twitter Instagram

Find your local office

Select location
© 2021 Novo Nordisk A/S Data Privacy Cookie policy Cookie settings

change